FDA Committee Delays Review of Pfizer-BioNTech’s COVID-19 Vaccine for Young Kids

12:31pm PST - February 11th, 2022    george washington - Time

The U.S. Food and Drug Administration (FDA) postponed a meeting to discuss the authorization of Pfizer-BioNTech’s COVID-19 vaccine for children younger than five, again pushing back the timeline for vaccinating the youngest Americans. The FDA’s Vaccines and R…